Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia-The PROGRESS Pilot Study
Phase of Trial: Phase III
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Hydroxyprogesterone (Primary)
- Indications Preeclampsia
- Focus Therapeutic Use
- Acronyms PROGRESS
- 16 Aug 2017 Status changed from not yet recruiting to recruiting.
- 18 May 2017 Planned number of patients changed from 30 to 60.
- 18 May 2017 Planned End Date changed from 1 Sep 2017 to 31 Jan 2018.